Algorithms; Biomarkers/blood; Blood Glucose/metabolism; Calibration; Computer Simulation; Equipment Design; Humans; Hypoglycemia/blood/diagnosis; Infant, Newborn; Monitoring, Physiologic/instrumentation/methods/standards; Monte Carlo Method; Predictive Value of Tests; Reference Standards; Reproducibility of Results; Time Factors; algorithm; continuous glucose monitor; hypoglycemia; intensive care unit; neonatal; recalibration
Abstract :
[en] Neonatal hypoglycemia is common and can cause serious brain injury. Continuous glucose monitoring (CGM) could improve hypoglycemia detection, while reducing blood glucose (BG) measurements. Calibration algorithms use BG measurements to convert sensor signals into CGM data. Thus, inaccuracies in calibration BG measurements directly affect CGM values and any metrics calculated from them. The aim was to quantify the effect of timing delays and calibration BG measurement errors on hypoglycemia metrics in newborn infants. Data from 155 babies were used. Two timing and 3 BG meter error models (Abbott Optium Xceed, Roche Accu-Chek Inform II, Nova Statstrip) were created using empirical data. Monte-Carlo methods were employed, and each simulation was run 1000 times. Each set of patient data in each simulation had randomly selected timing and/or measurement error added to BG measurements before CGM data were calibrated. The number of hypoglycemic events, duration of hypoglycemia, and hypoglycemic index were then calculated using the CGM data and compared to baseline values. Timing error alone had little effect on hypoglycemia metrics, but measurement error caused substantial variation. Abbott results underreported the number of hypoglycemic events by up to 8 and Roche overreported by up to 4 where the original number reported was 2. Nova results were closest to baseline. Similar trends were observed in the other hypoglycemia metrics. Errors in blood glucose concentration measurements used for calibration of CGM devices can have a clinically important impact on detection of hypoglycemia. If CGM devices are going to be used for assessing hypoglycemia it is important to understand of the impact of these errors on CGM data.
Disciplines :
Engineering, computing & technology: Multidisciplinary, general & others
Author, co-author :
Thomas, Felicity Louise ; Université de Liège - ULiège > Doct. sc. ingé. & techno. (électr., électro. & inf- paysage)
Signal, Mathew
Harris, Deborah L.
Weston, Philip J.
Harding, Jane E.
Shaw, Geoffrey M.
Chase, J. Geoffrey
Language :
English
Title :
Continuous glucose monitoring in newborn infants: how do errors in calibration measurements affect detected hypoglycemia?
Publication date :
2014
Journal title :
Journal of Diabetes Science and Technology
ISSN :
1932-3107
eISSN :
1932-2968
Publisher :
Diabetes Technology Society, United States - California
Harris DL, et al. Continuous glucose monitoring in newborn babies at risk of hypoglycemia. J Pediatr. 2010;157(2):198-202.
Stanley CA, Baker L. The causes of neonatal hypoglycemia. New Engl J Med. 1999;340(15):1200-1201. (Pubitemid 29177881)
Cornblath M, et al. Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics. 2000;105(5):1141- 1145. (Pubitemid 30243797)
Koh THHG, Eyre JA, Aynsleygreen A. Neonatal hypoglycemia - the controversy regarding definition. Arch Dis Child. 1988;63(11):1386-1388.
Beardsall K, et al. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed. 2005;90(4):F307-F310. (Pubitemid 40933391)
Signal M, et al. Continuous glucose monitors and the burden of tight glycemic control in critical care: can they cure the time cost? J Diabetes Sci Technol. 2010;4(3):625-635.
Pretty CG, et al. Hypoglycemia detection in critical care using continuous glucose monitors: an in silico proof of concept analysis. J Diabetes Sci Technol. 2010;4(1):15-24.
Aragon D. Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care. 2006;15(4):370-377. (Pubitemid 44859176)
Carayon P, Gurses AP. A human factors engineering conceptual framework of nursing workload and patient safety in intensive care units. Intensive Crit Care Nurs. 2005;21(5):284-301. (Pubitemid 41386874)
Ginsberg BH. Factors affecting blood glucose monitoring: sources of errors in measurement. J Diabetes Sci Technol. 2009;3(4):903-913.
Castle JR, Ward WK. Amperometric glucose sensors: sources of error and potential benefit of redundancy. J Diabetes Sci Technol. 2010;4(1):221-225.
Signal M, et al. Impact of retrospective calibration algorithms on hypoglycemia detection in newborn infants using continuous glucose monitoring. Diabetes Technol Ther. 2012;14(10):883-890.
Solnica B, Naskalski JW, Sieradzki J. Analytical performance of glucometers used for routine glucose self-monitoring of diabetic patients. Clin Chim Acta. 2003;331(1-2):29-35. (Pubitemid 36412023)
Kanji S, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778-2785. (Pubitemid 41816412)
Karon BS, et al. Accuracy of Roche Accu-Chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery. Am J Clin Pathol. 2007;127(6):919-926.
Hoedemaekers CW, et al. Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med. 2008;36(11):3062-3066.
Watkinson PJ, et al. The effects of precision, haematocrit, pH and oxygen tension on point-of-care glucose measurement in critically ill patients: a prospective study. Ann Clin Biochem. 2012;49(pt 2):144-151.
Critchell CD, et al. Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Med. 2007;33(12):2079-2084. (Pubitemid 350164561)
Nuntnarumit P, et al. Clinical performance of the new glucometer in the nursery and neonatal intensive care unit. Pediatr Int. 2011;53(2):218-223.
Ho HT, Yeung KW, Young BW. Evaluation of "point of care" devices in the measurement of low blood glucose in neonatal practice. Arch Dis Child Fetal Neonatal Ed. 2004;89(4):F356-F359. (Pubitemid 38869682)
Poirier JY, et al. Clinical and statistical evaluation of self-monitoring blood glucose meters. Diabetes Care. 1998;21(11):1919-1924.
Rao LV, et al. Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta. 2005;356(1-2):178-183. (Pubitemid 40779900)
Scott RJ, et al. Evaluation of multiple whole blood glucose methods compared with a laboratory plasma hexokinase reference assay. Point Care. 2008;7(2):43-46.
Nova. Nova Stat Strip Glucose Test Strip Packet Insert. Waltham, MA: Nova Biomedical; 2011.
Makaya T, Memmott A, Bustani P. Point-of-care glucose monitoring on the neonatal unit. J Paediatr Child Health. 2012;48(4):342-346.
Docherty PD, Chase JG, David T. Characterisation of the iterative integral parameter identification method. Med Biol Eng Comput. 2012;50(2):127-134.
Mahoney JJ, Ellison JM. Assessing glucose monitor performance- a standardized approach. Diabetes Technol Ther. 2007;9(6):545-552. (Pubitemid 350158796)
Jopling J, et al. Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system. Pediatrics. 2009;123(2): e333-e337.
Bequette BW. Continuous glucose monitoring: real-time algorithms for calibration, filtering, and alarms. J Diabetes Sci Technol. 2010;4(2):404-418.